Apimeds Pharmaceuticals US, Inc.
APUS
$3.99-9.11%
End of day · as of Oct 16, 2026, 8:00 PM ET
Mkt cap
$2.36M
EV/Sales
N/A
P/E ratio
N/A
Revenue
N/A
EPS (H1 2026)
$-33.83
Gross Margin
N/A
Profit Margin
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Use this APUS research hub for sector, financials, and filings — not a live tape.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Apimeds Pharmaceuticals US, Inc. (APUS) market capitalization is $2.4M on the latest cached snapshot.
Apimeds Pharmaceuticals US, Inc. (APUS) cached previous close $4.39; day range $3.98 – $4.27; volume 40,333. Session quote: https://lician.com/quote/apus
Apimeds Pharmaceuticals US, Inc. (APUS) latest cached earnings event is "APUS earnings" on Aug 18, 2026. Earnings calendar: https://lician.com/earnings
The latest cached APUS filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/apus